New research-focused proton therapy (PT) centre in Western Holland promoted by Delft University of Technology, Leiden University Medical Centre and Erasmus University Medical Centre Rotterdam.
The project consists of the construction and development of a new proton therapy research centre jointly promoted by three leading universities in the Netherlands: Erasmus University Medical Centre Rotterdam, Leiden University Medical Centre and Delft University of Technology. Their joint-venture for this project is named Holland PTC and aims at assessing the efficacy of proton technology by conducting basic and clinical research. At least 600 cancer patients will be included annually in clinical studies. The centre is expected to be built in the Delft University of Technology's science park and be functional from 2016 onwards. EIB will be involved in the financing of both the centre and the research and development (R&D) investment programme which will be carried out at HollandPTC.
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities. Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
The EIB is committed to achieving the highest possible level of transparency. The EIB Transparency Policy sets out how the EIB discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations.